Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'Going the distance': an independent cohort study of engagement and dropout among the first 100 000 referrals into a large-scale diabetes prevention program.1 passage
• 'MOVEdiabetes': a cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman.1 passage
• 'Never again will I be carefree': a qualitative study of the impact of hypoglycemia on quality of life among adults with type 1 diabetes.1 passage
• 'Turning the tide' on hyperglycemia in pregnancy: insights from multiscale dynamic simulation modeling.1 passage
• (untitled)1 passage
• 100 years on: the impact of the discovery of insulin on clinical outcomes.1 passage
• 30-minute postload plasma glucose levels during an oral glucose tolerance test predict the risk of future type 2 diabetes: the Hisayama Study.1 passage
• A Body shape index significantly predicts MRI-defined abdominal adipose tissue depots in non-obese Asian Indians with type 2 diabetes mellitus.1 passage
• A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway.1 passage
• A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities.1 passage
• A role of the adaptive immune system in glucose homeostasis.1 passage
• ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk.1 passage
• Abdominal obesity and hypertension are correlated with health-related quality of life in Taiwanese adults with metabolic syndrome.1 passage
• Abdominal visceral and subcutaneous adipose tissues in association with cardiometabolic risk in children and adolescents: the China Child and Adolescent Cardiovascular Health (CCACH) study.1 passage
• Accuracy of breath test for diabetes mellitus diagnosis: a systematic review and meta-analysis.1 passage
• Accuracy of glycosuria, random blood glucose and risk factors as selective screening tools for gestational diabetes mellitus in comparison with universal diagnosing.1 passage
• Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model.1 passage
• Acute effects of the food preservative propionic acid on glucose metabolism in humans.1 passage
• Acute post-disaster medical needs of patients with diabetes: emergency department use in New York City by diabetic adults after Hurricane Sandy.1 passage
• Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimen.1 passage
• Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.1 passage
• Addressing practical issues of predictive models translation into everyday practice and public health management: a combined model to predict the risk of type 2 diabetes improves incidence prediction and reduces the prevalence of missing risk predictions.1 passage
• Adequate 25-hydroxyvitamin D levels are inversely associated with various cardiometabolic risk factors in Chinese children, especially obese children.1 passage
• Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden.1 passage
• Adherence to antidiabetic treatment and impaired hypoglycemia awareness in type 2 diabetes mellitus assessed in Spanish community pharmacies: the ADHIFAC study.1 passage
• Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register.1 passage
• Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting.1 passage
• Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort.1 passage
• Adiponectin levels predict prediabetes risk: the Pathobiology of Prediabetes in A Biracial Cohort (POP-ABC) study.1 passage
• Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.1 passage
• Adverse effect of long work hours on incident diabetes in 7065 Ontario workers followed for 12 years.1 passage
• Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control.1 passage
• Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals.1 passage
• Air pollution and gestational diabetes mellitus: evidence from cohort studies.1 passage
• Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.1 passage
• All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany.1 passage
• Altered pain processing in patients with type 1 and 2 diabetes: systematic review and meta-analysis of pain detection thresholds and pain modulation mechanisms.1 passage
• American-Indian diabetes mortality in the Great Plains Region 2002-2010.1 passage
• Amyloid-related protein changes associated with dementia differ according to severity of hypoglycemia.1 passage
• An observational study of patient characteristics and mortality following hypoglycemia in the community.1 passage
• Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner.1 passage
• Analysis of the interaction effect of 48 SNPs and obesity on type 2 diabetes in Chinese Hans.1 passage
• Andalusian program for early detection of diabetic retinopathy: implementation and 15-year follow-up of a population-based screening program in Andalusia, Southern Spain.1 passage
• Anemia and incidence of dementia in patients with new-onset type 2 diabetes: a nationwide population-based cohort study.1 passage
• Anthropometric cut-offs to identify hyperglycemia in an Afro-Caribbean population: a cross-sectional population-based study from Barbados.1 passage
• Antidiabetic medication use during pregnancy: an international utilization study.1 passage
• Applications of physical performance measures to routine diabetes care for frailty prevention concept: fundamental data with grip strength, gait speed, timed chair stand speed, standing balance, and knee extension strength.1 passage
• Are depressive symptoms associated with quality of care in diabetes? Findings from a nationwide population-based study.1 passage
• Are newly introduced criteria for the diagnosis of gestational diabetes mellitus associated with improved pregnancy outcomes and/or increased interventions in New South Wales, Australia? A population-based data linkage study.1 passage
• Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study.1 passage
• Assessing guideline adherence in the management of type 1 diabetes mellitus in Australian children: a population-based sample survey.1 passage
• Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study.1 passage
• Association between C reactive protein and microvascular and macrovascular dysfunction in sub-Saharan Africans with and without diabetes: the RODAM study.1 passage
• Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality.1 passage
• Association between asymptomatic intracranial arterial stenosis and insulin resistance or diabetes mellitus: a cross-sectional study in rural Shandong, China.1 passage
• Association between brachial-ankle pulse wave velocity and risk of type 2 diabetes mellitus: results from a cohort study.1 passage
• Association between diabetes and edentulism and their joint effects on health status in 40 low and middle-income countries.1 passage
• Association between hemoglobin A1c variability and hypoglycemia-related hospitalizations in veterans with diabetes mellitus.1 passage
• Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis.1 passage
• Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.1 passage
• Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes.1 passage
• Association between race/ethnicity and the risk of amputation of lower extremities among medicare beneficiaries with diabetic foot ulcers and diabetic foot infections.1 passage
• Association between regional deprivation and type 2 diabetes incidence in Germany.1 passage
• Association between self-stigma and self-care behaviors in patients with type 2 diabetes: a cross-sectional study.1 passage
• Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.1 passage
• Association between the triglyceride to high-density lipoprotein cholesterol ratio and the risk of type 2 diabetes mellitus among Chinese elderly: the Beijing Longitudinal Study of Aging.1 passage
• Association between type 2 diabetes and chronic low back pain in general practices in Germany.1 passage
• Association between variability in body mass index and development of type 2 diabetes: Panasonic cohort study.1 passage
• Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis.1 passage
• Association of1 passage
• Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries.1 passage
• Association of diabetes with tooth loss in Hispanic/Latino adults: findings from the Hispanic Community Health Study/Study of Latinos.1 passage
• Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study.1 passage
• Association of endothelial dysfunction with incident prediabetes, type 2 diabetes and related traits: the KORA F4/FF4 study.1 passage
• Association of fasting plasma glucose variability with gestational diabetes mellitus: a nationwide population-based cohort study.1 passage
• Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes.1 passage
• Association of periodontal pocket area with type 2 diabetes and obesity: a cross-sectional study.1 passage
• Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study.1 passage
• Association of physiological and psychological health outcomes with physical activity and sedentary behavior in adults with type 2 diabetes.1 passage
• Association of prestroke glycemic status with stroke mortality.1 passage
• Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women.1 passage
• Association of severe hypoglycemia with depressive symptoms in patients with type 2 diabetes: the Fukuoka Diabetes Registry.1 passage
• Association of smoking cessation after new-onset type 2 diabetes with overall and cause-specific mortality among Korean men: a nationwide population-based cohort study.1 passage
• Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database.1 passage
• Association of the DASH dietary pattern with insulin resistance and diabetes in US Hispanic/Latino adults: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).1 passage
• Association of the Diabetes Health Plan with emergency room and inpatient hospital utilization: a Natural Experiment for Translation in Diabetes (NEXT-D) Study.1 passage
• Association of the IgG1 passage
• Association of type 1 diabetes and concentrations of drinking water components in Newfoundland and Labrador, Canada.1 passage
• Association of unhealthy dietary behaviors with renal function decline in patients with diabetes.1 passage
• Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.1 passage
• Association of vitamin B1 passage
• Associations between attainment of incentivized primary care indicators and incident lower limb amputation among those with type 2 diabetes: a population-based historical cohort study.1 passage
• Associations between changes in adipokines and exposure to fine and ultrafine particulate matter in ambient air in Beijing residents with and without pre-diabetes.1 passage
• Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes.1 passage
• Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank prospective cohort study.1 passage
• Associations between physical activity and trimethylamine1 passage
• Associations between social network properties and metabolic syndrome and the mediating effect of physical activity: findings from the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort.1 passage
• Associations of cells from both innate and adaptive immunity with lower nerve conduction velocity: the Maastricht Study.1 passage
• Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population.1 passage
• Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descent.1 passage
• Associations of pre-pregnancy impaired fasting glucose and body mass index among pregnant women without pre-existing diabetes with offspring being large for gestational age and preterm birth: a cohort study in China.1 passage
• Atypical diabetes: a diagnostic challenge.1 passage
• Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study.1 passage
• Basic lifestyle advice to individuals at high risk of type 2 diabetes: a 2-year population-based diabetes prevention study. The DE-PLAN intervention in the HUNT Study, Norway.1 passage
• BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin.1 passage
• Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study.1 passage
• Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later.1 passage
• Bidirectional temporal relationship between obesity and hyperinsulinemia: longitudinal observation from a Chinese cohort.1 passage
• Biomarkers of tubulointerstitial damage and function in type 1 diabetes.1 passage
• Birth weight modifies the relation between adulthood levels of insulin-like growth factor-1 and type 2 diabetes: a prospective cohort study.1 passage
• Birth weight, family history of diabetes and diabetes onset in schizophrenia.1 passage
• Blood glucose self-monitoring and internet diabetes management on A1C outcomes in patients with type 2 diabetes.1 passage
• Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case-control study.1 passage
• Breakfast skipping is associated with persistently increased arterial stiffness in patients with type 2 diabetes.1 passage
• Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial.1 passage
• Can peer support be cost saving? An economic evaluation of RAPSID: a randomized controlled trial of peer support in diabetes compared to usual care alone in East of England communities.1 passage
• Cardiac structure and function with and without metabolic syndrome: the Echocardiographic Study of Latinos (Echo-SOL).1 passage
• Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes.1 passage
• Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life.1 passage
• Cardiovascular risk factors from diagnosis in children with type 1 diabetes mellitus: a longitudinal cohort study.1 passage
• Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR).1 passage
• Caucasian and Asian difference in role of type 1 diabetes on large-for-gestational-age neonates.1 passage
• Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis.1 passage
• Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users.1 passage
• Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial.1 passage
• Cerebral small-vessel disease is associated with the severity of diabetic retinopathy in type 1 diabetes.1 passage
• Challenges of diabetes prevention in the real world: results and lessons from the Melbourne Diabetes Prevention Study.1 passage
• Change in clinical knowledge of diabetes among primary healthcare providers in Indonesia: repeated cross-sectional survey of 5105 primary healthcare facilities.1 passage
• Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997-1999 and 2008-2011.1 passage
• Changes in granule mobility and age contribute to changes in insulin secretion after desensitization or rest.1 passage
• Changes in insulin sensitivity and insulin secretion during pregnancy and post partum in women with gestational diabetes.1 passage
• Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study.1 passage
• Changes in secondhand smoke exposure levels and risk of type 2 diabetes in middle age: the Korean Genome and Epidemiology Study (KoGES).1 passage
• Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study.1 passage
• Characteristics of undiagnosed diabetes in men and women under the age of 50 years in the Indian subcontinent: the National Family Health Survey (NFHS-4)/Demographic Health Survey 2015-2016.1 passage
• Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease.1 passage
• Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood.1 passage
• Children with type 1 diabetes have elevated high-sensitivity C-reactive protein compared with a control group.1 passage
• Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.1 passage
• Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9.1 passage
• Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes.1 passage
• Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus.1 passage
• Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program.1 passage
• Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus.1 passage
• Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study.1 passage
• Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory.1 passage
• Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis.1 passage
• Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.1 passage
• Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes.1 passage
• Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system.1 passage
• Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.1 passage
• Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes.1 passage
• Clinical implication of blood glucose monitoring in general dental offices: the Ehime Dental Diabetes Study.1 passage
• Clinical phenotyping of newly diagnosed type 2 diabetes in Yemen.1 passage
• Clinical profile of diabetes mellitus in tuberculosis.1 passage
• Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates.1 passage
• Clinical significance of obstructive sleep apnea in patients with acute coronary syndrome in relation to diabetes status.1 passage
• Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus.1 passage
• Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.1 passage
• Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean.1 passage
• Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes.1 passage
• Combination of diabetes mellitus and lack of habitual physical activity is a risk factor for functional disability in Japanese.1 passage
• Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.1 passage
• Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes.1 passage
• Combined therapy of photobiomodulation and adipose-derived stem cells synergistically improve healing in an ischemic, infected and delayed healing wound model in rats with type 1 diabetes mellitus.1 passage
• Comorbid depression and risk of lower extremity amputation in people with diabetes: systematic review and meta-analysis.1 passage
• Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes.1 passage
• Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial.1 passage
• Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study.1 passage
• Comparison of a 'two-bag system' versus conventional treatment protocol ('one-bag system') in the management of diabetic ketoacidosis.1 passage
• Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national, multicentre, open-label randomized, controlled trial.1 passage
• Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies.1 passage
• Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.1 passage
• Comparison of several survey-based algorithms to ascertain type 1 diabetes among US adults with self-reported diabetes.1 passage
• Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study.1 passage
• Comparison of weight-based insulin titration (WIT) and glucose-based insulin titration using basal-bolus algorithm in hospitalized patients with type 2 diabetes: a multicenter, randomized, clinical study.1 passage
• Complexity of antidiabetic medication regimen is associated with increased diabetes-related distress in persons with type 2 diabetes mellitus.1 passage
• Compliance with guidelines for disease management in diabetes: results from the SwissDiab Registry.1 passage
• Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population.1 passage
• Components of diabetes prevalence in Denmark 1996-2016 and future trends until 2030.1 passage
• Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan.1 passage
• Consumption of fat-free dairy products is not associated with a lower risk of maternofetal adverse events.1 passage
• Contrast sensitivity to spatial gratings in moderate and dim light conditions in patients with diabetes in the absence of diabetic retinopathy.1 passage
• Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study.1 passage
• Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults.1 passage
• Cord serum metabolome and birth weight in patients with gestational diabetes treated with metformin, insulin, or diet alone.1 passage
• Core outcome set for diabetes after pregnancy prevention across the life span: international Delphi study.1 passage
• Corneal confocal microscopy compared with quantitative sensory testing and nerve conduction for diagnosing and stratifying the severity of diabetic peripheral neuropathy.1 passage
• Correlates of second-line type 2 diabetes medication selection in the USA.1 passage
• Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.1 passage
• Correlation of global risk assessment with cardiovascular complications in patients with diabetes mellitus living in Puerto Rico.1 passage
• Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus.1 passage
• Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK.1 passage
• Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus.1 passage
• Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus.1 passage
• Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City.1 passage
• Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease.1 passage
• Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes.1 passage
• Cre/CysC ratio may predict muscle composition and is associated with glucose disposal ability and macrovascular disease in patients with type 2 diabetes.1 passage
• Cross-sectional and prospective relationships of endogenous progestogens and estrogens with glucose metabolism in men and women: a KORA F4/FF4 Study.1 passage
• DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus.1 passage
• DNA methylation changes and improved sleep quality in adults with obstructive sleep apnea and diabetes.1 passage
• DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin-sulfonylurea dual therapy with inadequate control.1 passage
• Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46).1 passage
• Decrease in Choroidal Vascularity Index of Haller's layer in diabetic eyes precedes retinopathy.1 passage
• Decreased arterial distensibility and postmeal hyperinsulinemia in young Japanese women with family history of diabetes.1 passage
• Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study.1 passage
• Deficiency of C3a receptor attenuates the development of diabetic nephropathy.1 passage
• Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.1 passage
• Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms.1 passage
• Democratizing type 1 diabetes specialty care in the primary care setting to reduce health disparities: project extension for community healthcare outcomes (ECHO) T1D.1 passage
• Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c.1 passage
• Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.1 passage
• Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial.1 passage
• Detection of C-peptide in human hair and nail: a comparison between healthy persons and persons with type 1 diabetes.1 passage
• Determinants and correlates of adipose tissue insulin resistance index in Japanese women without diabetes and obesity.1 passage
• Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis.1 passage
• Determinants of longitudinal change in insulin clearance: the Prospective Metabolism and Islet Cell Evaluation cohort.1 passage
• Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry.1 passage
• Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods.1 passage
• Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial.1 passage
• Developing priorities to achieve health equity through diabetes translation research: a concept mapping study.1 passage
• Development and evaluation of a patient-centered quality indicator for the appropriateness of type 2 diabetes management.1 passage
• Development and validation of a clinical prediction rule for development of diabetic foot ulceration: an analysis of data from five cohort studies.1 passage
• Development and validation of a prediction model for insulin-associated hypoglycemia in non-critically ill hospitalized adults.1 passage
• Development and validation of an early pregnancy risk score for the prediction of gestational diabetes mellitus in Chinese pregnant women.1 passage
• Development and validation of an instrument to measure collaborative goal setting in the care of patients with diabetes.1 passage
• Development and validation of the DIabetes Severity SCOre (DISSCO) in 139 626 individuals with type 2 diabetes: a retrospective cohort study.1 passage
• Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes.1 passage
• Development of a multivariable prediction model for plantar foot ulcer recurrence in high-risk people with diabetes.1 passage
• Development of a prediction model for foot ulcer recurrence in people with diabetes using easy-to-obtain clinical variables.1 passage
• Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong.1 passage
• Diabetes and glucose disturbances in patients with psychosis in Sweden.1 passage
• Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA.1 passage
• Diabetes case finding in the emergency department, using HbA1c: an opportunity to improve diabetes detection, prevention, and care.1 passage
• Diabetes causal attributions among affected and unaffected individuals.1 passage
• Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients.1 passage
• Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature.1 passage
• Diabetes knowledge, risk perception, and quality of life among South Asian caregivers in young adulthood.1 passage
• Diabetes mellitus among adults with tuberculosis in the USA, 2010-2017.1 passage
• Diabetes mellitus as a risk factor for compression neuropathy: a longitudinal cohort study from southern Sweden.1 passage
• Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men.1 passage
• Diabetes mellitus is associated with elevated urinary pyrrole markers of γ-diketones known to cause axonal neuropathy.1 passage
• Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus.1 passage
• Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey.1 passage
• Diabetic muscle infarction: a systematic review.1 passage
• Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study.1 passage
• Dietary intake and eating patterns of young children with type 1 diabetes achieving glycemic targets.1 passage
• Dietary intake of adults with and without diabetes: results from NHANES 2013-2016.1 passage
• Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months.1 passage
• Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome.1 passage
• Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study.1 passage
• Discovering successful strategies for diabetic self-management: a qualitative comparative study.1 passage
• Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics.1 passage
• Disparities in recommended preventive care usage among persons living with diabetes in the Appalachian region.1 passage
• Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes.1 passage
• Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records.1 passage
• Does the effect of lifestyle intervention for individuals with diabetes vary by food insecurity status? A preplanned subgroup analysis of the REAL HEALTH randomized clinical trial.1 passage
• Drivers of weight loss in a CDC-recognized digital diabetes prevention program.1 passage
• Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).1 passage
• Early pregnancy plasma fatty acid profiles of women later diagnosed with gestational diabetes.1 passage
• Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs.1 passage
• Economic aspects in the management of diabetes in Italy.1 passage
• Economic burden of IADPSG gestational diabetes diagnostic criteria in China: propensity score matching analysis from a 7-year retrospective cohort.1 passage
• Education, immigration and income as risk factors for hemoglobin A1c >70 mmol/mol when diagnosed with type 2 diabetes or latent autoimmune diabetes in adult: a population-based cohort study.1 passage
• Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial.1 passage
• Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study.1 passage
• Effect of bariatric surgery on circulating and urinary mitochondrial DNA copy numbers in obesity with or without diabetes.1 passage
• Effect of diabetes on exosomal miRNA profile in patients with obesity.1 passage
• Effect of dose of behavioral weight loss treatment on glycemic control in adults with prediabetes.1 passage
• Effect of exposure to antibiotics on the gut microbiome and biochemical indexes of pregnant women.1 passage
• Effect of high-salt diet on blood pressure and body fluid composition in patients with type 1 diabetes: randomized controlled intervention trial.1 passage
• Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks.1 passage
• Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomized crossover trial.1 passage
• Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study.1 passage
• Effect of motivational interviewing on gestational weight gain and fetal growth in pregnant women with type 2 diabetes.1 passage
• Effect of periodontal treatment on diabetes-related healthcare costs: a retrospective study.1 passage
• Effect of regular exercise training on changes in HbA1c, BMI and VO1 passage
• Effect of socioeconomic deprivation on outcomes of diabetes complications in patients with type 2 diabetes mellitus: a nationwide population-based cohort study of South Korea.1 passage
• Effect of tap dance on plantar pressure, postural stability and lower body function in older patients at risk of diabetic foot: a randomized controlled trial.1 passage
• Effect of the Affordable Care Act on diabetes care at major health centers: newly detected diabetes and diabetes medication management.1 passage
• Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study.1 passage
• Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.1 passage
• Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.1 passage
• Effective diabetes complication management is a step toward a carbon-efficient planet: an economic modeling study.1 passage
• Effectiveness of a clinic-based randomized controlled intervention for type 2 diabetes management: an innovative model of intensified diabetes management in Mainland China (C-IDM study).1 passage
• Effectiveness of a structured educational intervention using psychological delivery methods in children and adolescents with poorly controlled type 1 diabetes: a cluster-randomized controlled trial of the CASCADE intervention.1 passage
• Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP).1 passage
• Effectiveness of plant-based diets in promoting well-being in the management of type 2 diabetes: a systematic review.1 passage
• Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA.1 passage
• Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics.1 passage
• Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study.1 passage
• Effects of Ocufolin on retinal microvasculature in patients with mild non-proliferative diabetic retinopathy carrying polymorphisms of the MTHFR gene.1 passage
• Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial.1 passage
• Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial.1 passage
• Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case-control study.1 passage
• Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.1 passage
• Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial.1 passage
• Effects of modified lipoproteins on human trophoblast cells: a role in pre-eclampsia in pregnancies complicated by diabetes.1 passage
• Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trial.1 passage
• Effects of the low carbohydrate, high fat diet on glycemic control and body weight in patients with type 2 diabetes: experience from a community-based cohort.1 passage
• Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome.1 passage
• Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.1 passage
• Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial.1 passage
• Efficacy and safety of patient-led versus physician-led titration of basal insulin in patients with uncontrolled type 2 diabetes: a meta-analysis of randomized controlled trials.1 passage
• Efficacy of clindamycin compared with amoxicillin-metronidazole after a 7-day regimen in the treatment of periodontitis in patients with diabetes: a randomized clinical trial.1 passage
• Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study).1 passage
• Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes.1 passage
• Egg ingestion in adults with type 2 diabetes: effects on glycemic control, anthropometry, and diet quality-a randomized, controlled, crossover trial.1 passage
• Elevated incidence rates of diabetes in Peru: report from PERUDIAB, a national urban population-based longitudinal study.1 passage
• Elevated serum adiponectin and tumor necrosis factor-α and decreased transthyretin in Japanese elderly women with low grip strength and preserved muscle mass and insulin sensitivity.1 passage
• Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.1 passage
• Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study.1 passage
• Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update.1 passage
• Engaging South Asian women with type 2 diabetes in a culturally relevant exercise intervention: a randomized controlled trial.1 passage
• Enrichment of Tc1 cells and T cell resistance to suppression are associated with dysglycemia in the visceral fat in human obesity.1 passage
• Enterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structure.1 passage
• Establishing the national top 10 priority research questions to improve diabetes-related foot health and disease: a Delphi study of Australian stakeholders.1 passage
• Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study.1 passage
• Estimating the impact of tax policy interventions on the projected number and prevalence of adults with type 2 diabetes in Germany between 2020 and 2040.1 passage
• Estimating the prevalence and incidence of type 2 diabetes using population level pharmacy claims data: a cross-sectional study.1 passage
• Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men.1 passage
• Ethnic differences in early glycemic control in childhood-onset type 1 diabetes.1 passage
• Ethnic differences in prediabetes and diabetes in the Suriname Health Study.1 passage
• Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening.1 passage
• Ethnic differences in serum lipids and lipoproteins in overweight/obese African-American and white American women with pre-diabetes: significance of NMR-derived lipoprotein particle concentrations and sizes.1 passage
• Ethnic variation in the conversion of prediabetes to diabetes among immigrant populations relative to Canadian-born residents: a population-based cohort study.1 passage
• Evaluation and management of COVID-19-related severity in people with type 2 diabetes.1 passage
• Evaluation of AUSDRISK as a screening tool for lifestyle modification programs: international implications for policy and cost-effectiveness.1 passage
• Evaluation of a type 2 diabetes prevention program using a commercial weight management provider for non-diabetic hyperglycemic patients referred by primary care in the UK.1 passage
• Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control study.1 passage
• Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2.1 passage
• Evaluation of vitamin D relationship with type 2 diabetes and systolic blood pressure.1 passage
• Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes.1 passage
• Exercise capacity is associated with hospital readmission among patients with diabetes.1 passage
• Exercise modes and their association with hypoglycemia episodes in adults with type 1 diabetes mellitus: a systematic review.1 passage
• Exercise training improves adipose tissue metabolism and vasculature regardless of baseline glucose tolerance and sex.1 passage
• Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.1 passage
• Experiences and challenges of adults living with type 2 diabetes mellitus presenting at the University Teaching Hospital in Lusaka, Zambia.1 passage
• Experiences and perspectives of the parents of emerging adults living with type 1 diabetes.1 passage
• Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond.1 passage
• Exploring abnormal glucose metabolism in pregnancy among Australian Chinese migrants.1 passage
• Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data.1 passage
• Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey.1 passage
• Expression of clock gene1 passage
• Expression of the NEK7/NLRP3 inflammasome pathway in patients with diabetic lower extremity arterial disease.1 passage
• Eye care providers' emerging roles in early detection of diabetes and management of diabetic changes to the ocular surface: a review.1 passage
• FINDRISC in Latin America: a systematic review of diagnosis and prognosis models.1 passage
• FOXN3 hyperglycemic risk allele and insulin sensitivity in humans.1 passage
• Factors associated with high oxidative stress in patients with type 2 diabetes: a meta-analysis of two cohort studies.1 passage
• Factors associated with missed appointments by adults with type 2 diabetes mellitus: a systematic review.1 passage
• Factors associated with undiagnosed type 2 diabetes in Germany: results from German Health Interview and Examination Survey for Adults 2008-2011.1 passage
• Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients.1 passage
• Factors influencing the effect of mindfulness-based interventions on diabetes distress: a meta-analysis.1 passage
• Factors influencing variation in participation in the National Diabetes Audit and the impact on the Quality and Outcomes Framework indicators of diabetes care management.1 passage
• Feasibility of computer-generated telephonic message-based follow-up system among healthcare workers with diabetes: a randomized controlled trial.1 passage
• Feasibility study of real-time online text-based CBT to support self-management for people with type 1 diabetes: the Diabetes On-line Therapy (DOT) Study.1 passage
• Fetuin-A and fetal growth in gestational diabetes mellitus.1 passage
• Filling gaps in type 1 diabetes and exercise research: a scoping review and priority-setting project.1 passage
• Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.1 passage
• Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings.1 passage
• Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.1 passage
• Follow-up after gestational diabetes: a fixable gap in women's preventive healthcare.1 passage
• Frailty predicts a higher risk of incident urolithiasis in 525 368 patients with diabetes mellitus: a population-based study.1 passage
• Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity.1 passage
• Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study.1 passage
• GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes.1 passage
• GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice.1 passage
• Gender differences in the effect of diabetes mellitus and its treatment on osteoarthritic pain.1 passage
• Gender-related affecting factors of prediabetes on its 10-year outcome.1 passage
• Gene expression profile of whole blood cells differs in pregnant women with positive screening and negative diagnosis for gestational diabetes.1 passage
• Genetic factors and risk of type 2 diabetes among women with a history of gestational diabetes: findings from two independent populations.1 passage
• Genetic variants associated with beta-cell function and insulin sensitivity potentially influence bile acid metabolites and gestational diabetes mellitus in a Chinese population.1 passage
• Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects.1 passage
• Geographical clustering and socioeconomic factors associated with hypoglycemic events requiring emergency assistance in Andalusia (Spain).1 passage
• Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study.1 passage
• Gestational diabetes mellitus treatment reduces obesity-induced adverse pregnancy and neonatal outcomes: the St. Carlos gestational study.1 passage
• Gestational diabetes status and dietary intake modify maternal and cord blood allostatic load markers.1 passage
• Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies.1 passage
• Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System.1 passage
• Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.1 passage
• Glucose metabolism among obese and non-obese children of mothers with gestational diabetes.1 passage
• Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.1 passage
• Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes.1 passage
• Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study.1 passage
• Glutathione S-transferases gene polymorphism influence on the age of diabetes type 2 onset.1 passage
• Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients' conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study.1 passage
• Glycated hemoglobin (HbA1c) as diagnostic criteria for diabetes: the optimal cut-off points values for the Pakistani population; a study from second National Diabetes Survey of Pakistan (NDSP) 2016-2017.1 passage
• Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts.1 passage
• Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial.1 passage
• Glycemic excursion minimization in the management of type 2 diabetes: a novel intervention tested in a randomized clinical trial.1 passage
• Glycemic responses to strenuous training in male professional cyclists with type 1 diabetes: a prospective observational study.1 passage
• Glycemic variability and cardiovascular disease in patients with type 2 diabetes.1 passage
• Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer.1 passage
• Habitual snoring, adiposity measures and risk of type 2 diabetes in 0.5 million Chinese adults: a 10-year cohort.1 passage
• HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM.1 passage
• HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study.1 passage
• HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes.1 passage
• HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes.1 passage
• HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs.1 passage
• Health literacy and exercise interventions on clinical outcomes in Chinese patients with diabetes: a propensity score-matched comparison.1 passage
• Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study.1 passage
• Health-related quality of life and its associated factors among adult patients with type II diabetes attending Mizan Tepi University Teaching Hospital, Southwest Ethiopia.1 passage
• Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England.1 passage
• Healthy Eating and Active Lifestyles for Diabetes (HEAL-D), a culturally tailored self-management education and support program for type 2 diabetes in black-British adults: a randomized controlled feasibility trial.1 passage
• Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose.1 passage
• Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE.1 passage
• Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.1 passage
• Hepatic fat and glucose tolerance in women with recent gestational diabetes.1 passage
• Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth.1 passage
• Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report.1 passage
• Heredity of type 2 diabetes confers increased susceptibility to oxidative stress and inflammation.1 passage
• High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-control study.1 passage
• High or low glycemic index (GI) meals at dinner results in greater postprandial glycemia compared with breakfast: a randomized controlled trial.1 passage
• High prevalence of cardiovascular risk factors and insulin resistance 6 years after hyperglycemia first detected in pregnancy in Cape Town, South Africa.1 passage
• High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort.1 passage
• High probability of false-positive gestational diabetes mellitus diagnosis during early pregnancy.1 passage
• High-serum carotenoids associated with lower risk for developing type 2 diabetes among Japanese subjects: Mikkabi cohort study.1 passage
• Higher circulating adiponectin and lower orosomucoid were associated with postload glucose ≤70 mg/dL, a possible inverse marker for dysglycemia, in young Japanese women.1 passage
• Higher circulating orosomucoid, an acute-phase protein, and reduced glucose-induced insulin secretion in middle-aged Japanese people with prediabetes.1 passage
• Higher fasting plasma glucose is associated with striatal and hippocampal shape differences: the 2sweet project.1 passage
• Hispanic representation in diabetes cardiovascular outcomes trials.1 passage
• Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor/p38 MAPK axis.1 passage
• Histological and transcriptional characterization of the pancreatic acinar tissue in type 1 diabetes.1 passage
• How information about the time requirements and legacy effects of treatments influence decision-making in patients with diabetes and hypertension.1 passage
• Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus.1 passage
• Huntingtin-associated protein 1 plays an essential role in the pathogenesis of type 2 diabetes by regulating the translocation of GLUT4 in mouse adipocytes.1 passage
• Hyperinsulinemia and sulfonylurea use are independently associated with left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus with suboptimal blood glucose control.1 passage
• Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen.1 passage
• Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients.1 passage
• Identifying risk for type 2 diabetes in different age cohorts: does one size fit all?1 passage
• Identifying sustainable lifestyle strategies for maintaining good glycemic control: a validation of qualitative findings.1 passage
• Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes.1 passage
• Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis.1 passage
• Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia.1 passage
• Impact of Ramadan fasting on glucose levels in women with gestational diabetes mellitus treated with diet alone or diet plus metformin: a continuous glucose monitoring study.1 passage
• Impact of a primary healthcare quality improvement program on diabetes in Canada: evaluation of the Quality Improvement and Innovation Partnership (QIIP).1 passage
• Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes.1 passage
• Impact of a type 2 diabetes diagnosis on mental health, quality of life, and social contacts: a longitudinal study.1 passage
• Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan.1 passage
• Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.1 passage
• Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository.1 passage
• Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes.1 passage
• Impact of malnutrition on survival and healthcare utilization in Medicare beneficiaries with diabetes: a retrospective cohort analysis.1 passage
• Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycemia and diabetes.1 passage
• Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis.1 passage
• Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway.1 passage
• Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin.1 passage
• Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population.1 passage
• Impact of type 2 diabetes on postoperative outcome after hip fracture: nationwide population-based study in Taiwan.1 passage
• Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection.1 passage
• Impact of weight loss on waist circumference and the components of the metabolic syndrome.1 passage
• Impaired exocrine pancreatic function in different stages of type 1 diabetes.1 passage
• Impaired fasting glucose and development of chronic kidney disease in non-diabetic population: a Mendelian randomization study.1 passage
• Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study.1 passage
• Impaired glucose regulation, depressive symptoms, and health-related quality of life.1 passage
• Implementation of routine foot check in patients with diabetes on hemodialysis: associations with outcomes.1 passage
• Improved diabetes control among low-income Mexican Americans through community-clinical interventions: results of an RCT.1 passage
• Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study.1 passage
• Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey.1 passage
• Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).1 passage
• Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.1 passage
• Improving interpretability of individual Diabetes Symptom Checklist-Revised (DSC-R) scores: the role of patient characteristics.1 passage
• Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium.1 passage
• Improving preparedness of medical students and junior doctors to manage patients with diabetes.1 passage
• Improving the American Diabetes Association Framework for individualizing treatment in older adults: evaluating life expectancy.1 passage
• Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study.1 passage
• Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase II.1 passage
• Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015.1 passage
• Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study.1 passage
• Incidence and outcomes of hospitalization for community-acquired, ventilator-associated and non-ventilator hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain.1 passage
• Incidence and pathophysiology of diabetes in South Asian adults living in India and Pakistan compared with US blacks and whites.1 passage
• Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: results of the cohort di@bet.es study.1 passage
• Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK.1 passage
• Incidence and seasonality of type 1 diabetes: a population-based 3-year cohort study using the National Database in Japan.1 passage
• Incidence of diabetes and prediabetes and predictors of glycemic change among South Asians in the USA: the MASALA study.1 passage
• Incidence of diabetes in South Asian young adults compared to Pima Indians.1 passage
• Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50.1 passage
• Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008-2012: association with hemoglobin A1 passage
• Incidence of type 2 diabetes in familial combined hyperlipidemia.1 passage
• Incorporating patients' perspectives into the initial stages of core outcome set development: a rapid review of qualitative studies of type 2 diabetes.1 passage
• Increased placental mitochondrial fusion in gestational diabetes mellitus: an adaptive mechanism to optimize feto-placental metabolic homeostasis?1 passage
• Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia.1 passage
• Increased risk of hospital-acquired foot ulcers in people with diabetes: large prospective study and implications for practice.1 passage
• Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.1 passage
• Increasing metformin concentrations and its excretion in both rat and porcine ex vivo normothermic kidney perfusion model.1 passage
• Independent effects of 15 commonly prescribed drugs on all-cause mortality among US elderly patients with type 2 diabetes mellitus.1 passage
• Indirect measure of visceral adiposity 'A Body Shape Index' (ABSI) is associated with arterial stiffness in patients with type 2 diabetes.1 passage
• Individual and combined contributions of age-specific and sex-specific pulse pressure and brachial-ankle pulse wave velocity to the risk of new-onset diabetes mellitus.1 passage
• Individual free fatty acids have unique associations with inflammatory biomarkers, insulin resistance and insulin secretion in healthy and gestational diabetic pregnant women.1 passage
• Individuals at high risk for type 2 diabetes invited to a lifestyle program: characteristics of participants versus non-participants (the HUNT Study) and 24-month follow-up of participants (the VEND-RISK Study).1 passage
• Inequalities in glycemic management in people living with type 2 diabetes mellitus and severe mental illnesses: cohort study from the UK over 10 years.1 passage
• Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease.1 passage
• Influence of guideline adherence and parameter control on the clinical outcomes in patients with diabetic nephropathy.1 passage
• Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study.1 passage
• Inpatient HbA1c testing: a prospective observational study.1 passage
• Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost.1 passage
• Insomnia is associated with an increased risk of type 2 diabetes in the clinical setting.1 passage
• Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport.1 passage
• Insulin pricing and other major diabetes-related concerns in the USA: a study of 46 407 tweets between 2017 and 2019.1 passage
• Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels.1 passage
• Insulin resistance of protein anabolism accompanies that of glucose metabolism in lean, glucose-tolerant offspring of persons with type 2 diabetes.1 passage
• Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.1 passage
• Insulin sensitivity predicts cognitive decline in individuals with prediabetes.1 passage
• Insulin sensitivity variations in apparently healthy Arab male subjects: correlation with insulin and C peptide.1 passage
• Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial.1 passage
• Insulin use and new diabetes after acceptance for bariatric surgery: comparison of outcomes after completion of surgery or withdrawal from the program.1 passage
• Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort.1 passage
• Integrative health coaching: a behavior skills approach that improves HbA1c and pharmacy claims-derived medication adherence.1 passage
• Intensity of statin therapy and new hospitalizations for heart failure in patients with type 2 diabetes.1 passage
• Intent-to-treat analysis of a simultaneous multisite telehealth diabetes prevention program.1 passage
• Intentional weight loss as a predictor of type 2 diabetes occurrence in a general adult population.1 passage
• Interaction between sex and rurality on the prevalence of diabetes in Guyana: a nationally representative study.1 passage
• Internet-delivered cognitive behaviour therapy for depression in people with diabetes: study protocol for a randomised controlled trial.1 passage
• Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial.1 passage
• Intraperitoneal, subcutaneous and intravenous glucagon delivery and subsequent glucose response in rats: a randomized controlled crossover trial.1 passage
• Iron overload is related to elevated blood glucose levels in obese children and aggravates high glucose-induced endothelial cell dysfunction in vitro.1 passage
• Is chronic low back pain a risk factor for diabetes? The Nord-Trøndelag Health Study.1 passage
• Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010.1 passage
• Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study.1 passage
• Islet inflammation is associated with pancreatic fatty infiltration and hyperglycemia in type 2 diabetes.1 passage
• Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes.1 passage
• Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults.1 passage
• KGF-2 and FGF-21 poloxamer 407 hydrogel coordinates inflammation and proliferation homeostasis to enhance wound repair of scalded skin in diabetic rats.1 passage
• Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis.1 passage
• Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes.1 passage
• Lack of association of genetic variants for diabetic retinopathy in Taiwanese patients with diabetic nephropathy.1 passage
• Lack of effect of1 passage
• Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).1 passage
• Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes.1 passage
• Levels of ankle-brachial index and the risk of diabetes mellitus complications.1 passage
• Lifestyle interventions for type 2 diabetes management among migrants and ethnic minorities living in industrialized countries: a systematic review and meta-analyses.1 passage
• Lifetime duration of lactation and chronic inflammation among middle-aged women with a history of gestational diabetes.1 passage
• Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996-2016.1 passage
• Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria.1 passage
• Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial.1 passage
• Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies.1 passage
• Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk.1 passage
• Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population.1 passage
• Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies.1 passage
• Long-term BMI change trajectories in Chinese adults and its association with the hazard of type 2 diabetes: evidence from a 20-year China Health and Nutrition Survey.1 passage
• Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises.1 passage
• Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study.1 passage
• Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial.1 passage
• Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes.1 passage
• Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins21 passage
• Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study.1 passage
• Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA.1 passage
• Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).1 passage
• Long-term tracking of fasting blood glucose variability and peripheral artery disease in people without diabetes.1 passage
• Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012-2018.1 passage
• Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study.1 passage
• Longitudinal associations between family conflict, parent engagement, and metabolic control in children with recent-onset type 1 diabetes.1 passage
• Longitudinal relationship of diabetes and depressive symptoms in older adults from Mexico: a secondary data analysis.1 passage
• Lost opportunities to prevent early onset type 2 diabetes mellitus after a pregnancy complicated by gestational diabetes.1 passage
• Low socioeconomic status is associated with adverse events in children and teens on insulin pumps under a universal access program: a population-based cohort study.1 passage
• Low-cost exercise interventions improve long-term cardiometabolic health independently of a family history of type 2 diabetes: a randomized parallel group trial.1 passage
• Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial.1 passage
• Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes.1 passage
• Lower extremity MRI following 10-week supervised exercise intervention in patients with diabetic peripheral neuropathy.1 passage
• Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis.1 passage
• Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus.1 passage
• Lower glycemic load meals reduce diurnal glycemic oscillations in women with risk factors for gestational diabetes.1 passage
• Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes.1 passage
• Lower resource utilization for patients with healed diabetic foot ulcers during participation in a prevention program with foot temperature monitoring.1 passage
• Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes.1 passage
• Lower vitamin D levels are associated with higher blood glucose levels in Asian Indian women with pre-diabetes: a population-based cross-sectional study in North India.1 passage
• Management of type 2 diabetes in chronic kidney disease.1 passage
• Maternal diabetes and the risk of feeding and eating disorders in offspring: a national population-based cohort study.1 passage
• Maternal glycemic parameters and adverse pregnancy outcomes among high-risk pregnant women.1 passage
• Maternal postload 1-hour glucose level during pregnancy and offspring's overweight/obesity status in preschool age.1 passage
• Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes.1 passage
• Mealtime insulin BOLUS score increases prior to clinic visits in youth with type 1 diabetes.1 passage
• Medical nutrition therapy for gestational diabetes mellitus based on Mediterranean Diet principles: a subanalysis of the St Carlos GDM Prevention Study.1 passage
• Medication adherence and glycemic control among newly diagnosed diabetes patients.1 passage
• Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort.1 passage
• Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.1 passage
• Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study.1 passage
• Medication-induced hyperglycemia: pediatric perspective.1 passage
• Mediterranean style diet is associated with low risk of new-onset diabetes after renal transplantation.1 passage
• Mendelian randomization study of serum uric acid levels and diabetes risk: evidence from the Dongfeng-Tongji cohort.1 passage
• Mentored implementation to initiate a diabetes program in an underserved community: a pilot study.1 passage
• Metabolic characteristics of Africans with normal glucose tolerance and elevated 1-hour glucose: insight from the Africans in America study.1 passage
• Metabolic recovery after weight loss surgery is reflected in serum microRNAs.1 passage
• Metabolites in the association between early-life famine exposure and type 2 diabetes in adulthood over a 5-year follow-up period.1 passage
• Metabolomic, hormonal and physiological responses to hypoglycemia versus euglycemia during exercise in adults with type 1 diabetes.1 passage
• Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus.1 passage
• Metformin and breast and gynecological cancer risk among women with diabetes.1 passage
• Metformin and statin use associate with plasma protein1 passage
• Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age.1 passage
• Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes.1 passage
• Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus.1 passage
• Mexican American and South Asian population-based cohorts reveal high prevalence of type 2 diabetes and crucial differences in metabolic phenotypes.1 passage
• Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.1 passage
• Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands.1 passage
• Mitochondrial DNA copy number and diabetes: the Atherosclerosis Risk in Communities (ARIC) study.1 passage
• Mixed methods study of engagement in behaviors to prevent type 2 diabetes among employees with pre-diabetes.1 passage
• Model to improve cardiometabolic risk factors in Palestine refugees with diabetes mellitus attending UNRWA health centers.1 passage
• Molecular and clinical characteristics of monogenic diabetes mellitus in southern Chinese children with onset before 3 years of age.1 passage
• Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.1 passage
• Monitoring for proteinuria in patients with type 2 diabetes mellitus.1 passage
• Motivational Interview to improve vascular health in Adolescents with poorly controlled type 1 Diabetes (MIAD): a randomized controlled trial.1 passage
• Mouse model of metformin-induced diarrhea.1 passage
• Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes.1 passage
• Multimethod, multidataset analysis reveals paradoxical relationships between sociodemographic factors, Hispanic ethnicity and diabetes.1 passage
• Multiple complications among people with diabetes from Finland: an 18-year follow-up in 1994-2011.1 passage
• Multiple sleep dimensions and type 2 diabetes risk among women in the Sister Study: differences by race/ethnicity.1 passage
• Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period.1 passage
• Need to improve awareness and treatment compliance in high-risk patients for diabetic complications in Nepal.1 passage
• Neighborhood walkability and pre-diabetes incidence in a multiethnic population.1 passage
• Neighborhood walkability and risk of gestational diabetes.1 passage
• Neonatal amygdala microstructure mediates the relationship between gestational glycemia and offspring adiposity.1 passage
• Neuropathic pain is not associated with serum vitamin D but is associated with female gender in patients with type 2 diabetes mellitus.1 passage
• Neurovascular coupling alterations in type 2 diabetes: a 5-year longitudinal MRI study.1 passage
• New clinical screening strategy to distinguish1 passage
• New directions in incidence and prevalence of diagnosed diabetes in the USA.1 passage
• Newly diagnosed type 2 diabetes in an ethnic minority population: clinical presentation and comparison to other populations.1 passage
• No consistent association between processes-of-care and health-related quality of life among patients with diabetes: a missing link?1 passage
• Non-adherence to eye care in people with diabetes.1 passage
• Non-invasive monitoring of pharmacodynamics during the skin wound healing process using multimodal optical microscopy.1 passage
• Normative data on cardiovascular autonomic function in Greenlandic Inuit.1 passage
• Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.1 passage
• Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study.1 passage
• Obesity susceptible novel DNA methylation marker on regulatory region of inflammation gene: results from the Korea Epigenome Study (KES).1 passage
• Obstructive sleep apnea in adults with type 1 and type 2 diabetes: perspectives from a quality improvement initiative in a university-based diabetes center.1 passage
• Occupational distribution of metabolic syndrome prevalence and incidence differs by sex and is not explained by age and health behavior: results from 75 000 Dutch workers from 40 occupational groups.1 passage
• Ocular screening adherence across Hispanic/Latino heritage groups with diabetes: results from the Ocular SOL ancillary to the Miami site of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).1 passage
• Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands.1 passage
• One-hour plasma glucose combined with skin autofluorescence identifies subjects with pre-diabetes: the DIAPASON study.1 passage
• One-year intensive lifestyle intervention and improvements in health-related quality of life and mental health in persons with type 2 diabetes: a secondary analysis of the U-TURN randomized controlled trial.1 passage
• Opinions of vascular surgeons and podiatrists in Australia and New Zealand on the use of hyperbaric oxygen therapy for lower limb ulcers.1 passage
• Optical coherence tomography: a novel imaging approach to visualize and quantify cutaneous microvascular structure and function in patients with diabetes.1 passage
• Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus.1 passage
• Orai-IGFBP3 signaling complex regulates high-glucose exposure-induced increased proliferation, permeability, and migration of human coronary artery endothelial cells.1 passage
• Oral diabetes medication monotherapy and short-term mortality in individuals with type 2 diabetes and coronary artery disease.1 passage
• Outcomes after surgery in patients with diabetes who used metformin: a retrospective cohort study based on a real-world database.1 passage
• Outcomes of pancreas transplantation in older diabetic patients.1 passage
• Overexpression of lipoic acid synthase gene alleviates diabetic nephropathy1 passage
• Oxidized LDL, insulin sensitivity and beta-cell function in newborns.1 passage
• PDCD4 deficiency ameliorates left ventricular remodeling and insulin resistance in a rat model of type 2 diabetic cardiomyopathy.1 passage
• PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment.1 passage
• PERsistent Sitagliptin treatment & Outcomes (PERS&O 2.0) study, long-term results: a real-world observation on DPP4-inhibitor effectiveness.1 passage
• Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.1 passage
• Participation in structured diabetes mellitus self-management education program and association with lifestyle behavior: results from a population-based study.1 passage
• Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) Study: design of lifestyle intervention.1 passage
• Patients' perspectives on social and goal-based comparisons regarding their diabetes health status.1 passage
• Patients' perspectives on the barriers to referral after telescreening for diabetic retinopathy in communities.1 passage
• Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes.1 passage
• Patterns and correlates of use of evidence-based interventions to control diabetes by local health departments across the USA.1 passage
• Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated1 passage
• Perceived barriers and enablers to the provision of diabetic retinopathy screening for young adults: a cross-sectional survey of healthcare professionals working in the UK National Diabetic Eye Screening Programme.1 passage
• Perceived diabetes risk and related determinants in individuals with high actual diabetes risk: results from a nationwide population-based survey.1 passage
• Perceived ethical acceptability of financial incentives to improve diabetic eye screening attendance.1 passage
• Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China.1 passage
• Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus.1 passage
• Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus.1 passage
• Periconception glycemic control and congenital anomalies in women with pregestational diabetes.1 passage
• Periodontitis as a possible early sign of diabetes mellitus.1 passage
• Periodontitis, edentulism and glycemic control in patients with type 2 diabetes: a cross-sectional study.1 passage
• Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry.1 passage
• Person-centered diabetes care and patient activation in people with type 2 diabetes.1 passage
• Persons with type 1 diabetes have low blood oxygen levels in the supine and standing body positions.1 passage
• Pharmacologically treated diabetes and hospitalization among older Norwegians receiving homecare services from 2009 to 2014: a nationwide register study.1 passage
• Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors.1 passage
• Physical activity and cardiometabolic health in adolescents with type 2 diabetes: a cross-sectional study.1 passage
• Physical activity, sedentary leisure-time and risk of incident type 2 diabetes: a prospective study of 512 000 Chinese adults.1 passage
• Physical behaviors and chronotype in people with type 2 diabetes.1 passage
• Physicians' real-world experience with IDegLira: results of a European survey.1 passage
• Physiological and behavioral risk factors of type 2 diabetes mellitus in rural India.1 passage
• Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.1 passage
• Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study.1 passage
• Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns.1 passage
• Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials.1 passage
• Plasma 1-deoxysphingolipids are predictive biomarkers for type 2 diabetes mellitus.1 passage
• Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches.1 passage
• Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.1 passage
• Plasma glucose and insulin response to two oral nutrition supplements in adults with type 2 diabetes mellitus.1 passage
• Plasma heat shock protein response to euglycemia in type 2 diabetes.1 passage
• Plasma lipidomics profile in pregnancy and gestational diabetes risk: a prospective study in a multiracial/ethnic cohort.1 passage
• Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes.1 passage
• Plasma protein1 passage
• Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial.1 passage
• Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years.1 passage
• Positive reinforcement by general practitioners is associated with greater physical activity in adults with type 2 diabetes.1 passage
• Post hoc efficacy and safety analysis of insulin glargine/lixisenatide fixed- ratio combination in North American patients compared with the rest of world.1 passage
• Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.1 passage
• Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study.1 passage
• Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: Flow-mediated Dilation Japan (FMD-J) study.1 passage
• Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania.1 passage
• Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes.1 passage
• Predictive models of medication non-adherence risks of patients with T2D based on multiple machine learning algorithms.1 passage
• Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program.1 passage
• Predictors of 30-day unplanned hospital readmission among adult patients with diabetes mellitus: a systematic review with meta-analysis.1 passage
• Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes.1 passage
• Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes.1 passage
• Pregnancy outcomes in women with onset of type 1 diabetes mellitus less than 18 years of age.1 passage
• Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks.1 passage
• Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study.1 passage
• Presentation, pathology and prognosis of renal disease in type 2 diabetes.1 passage
• Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus.1 passage
• Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes.1 passage
• Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study.1 passage
• Prevalence and trends in dietary supplement use among US adults with diabetes: the National Health and Nutrition Examination Surveys, 1999-2014.1 passage
• Prevalence of bone fracture and its association with severe hypoglycemia in Japanese patients with type 1 diabetes.1 passage
• Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study.1 passage
• Prevalence of diagnosed diabetes in American Indian and Alaska Native adults, 2006-2017.1 passage
• Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.1 passage
• Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS).1 passage
• Prevalence, awareness, treatment, and control of diabetes mellitus by depressive symptom severity: a cross-sectional analysis of NHANES 2011-2016.1 passage
• Prevalence, control, and treatment of diabetes, hypertension, and high cholesterol in the Amish.1 passage
• Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996-2016.1 passage
• Prevalence, incidence and predictors of cardiovascular risk factors: longitudinal data from rural and urban South India and comparison with global data.1 passage
• Preventing diabetes after pregnancy with gestational diabetes in a Cree community: an inductive thematic analysis.1 passage
• Primary care physicians' utilization of type 2 diabetes screening guidelines and referrals to behavioral interventions: a survey-linked retrospective study.1 passage
• Problem-solving therapy for adults with diabetic retinopathy and diabetes-specific distress: a pilot randomized controlled trial.1 passage
• Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan.1 passage
• Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.1 passage
• Proinsulin to insulin ratio is associated with incident type 2 diabetes but not with vascular complications in the KORA F4/FF4 study.1 passage
• Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.1 passage
• Projected burden of type 2 diabetes mellitus-related complications in Singapore until 2050: a Bayesian evidence synthesis.1 passage
• Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes.1 passage
• Providing culturally sensitive diabetes self-management education and support for black African and Caribbean communities: a qualitative exploration of the challenges experienced by healthcare practitioners in inner London.1 passage
• Psychological barriers to optimal insulin therapy: more concerns in adolescent females than males.1 passage
• Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis.1 passage
• Psychometric testing of the Norwegian Diabetes Health Profile (DHP-18) in patients with type 1 diabetes.1 passage
• Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore.1 passage
• Quality gaps in screening and monitoring for postoperative hyperglycemia in a Canadian hospital: a retrospective cohort study.1 passage
• Quality of care in rural youth with type 1 diabetes: a cross-sectional pilot assessment.1 passage
• Quantifying dermal microcirculatory changes of neuropathic and neuroischemic diabetic foot ulcers using spatial frequency domain imaging: a shade of things to come?1 passage
• RUNX1 can mediate the glucose and O-GlcNAc-driven proliferation and migration of human retinal microvascular endothelial cells.1 passage
• Random plasma glucose levels and cause-specific mortality among Chinese adults without known diabetes: an 11-year prospective study of 450,000 people.1 passage
• Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND): study design and baseline characteristics of patients with type 2 diabetes newly initiating oral antidiabetic drug monotherapy in Japan.1 passage
• Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs).1 passage
• Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada.1 passage
• Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.1 passage
• Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene.1 passage
• Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study.1 passage
• Recommendations for management of diabetes and its complications during Hajj (Muslim pilgrimage).1 passage
• Recommendations for management of diabetes during Ramadan: update 2015.1 passage
• Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus.1 passage
• Recovery of premorbid BMI trajectory without overshoot during the first year of treatment of children with type 1 diabetes.1 passage
• Recruitment, retention, and training of people with type 2 diabetes as diabetes prevention mentors (DPM) to support a healthcare professional-delivered diabetes prevention program: the Norfolk Diabetes Prevention Study (NDPS).1 passage
• Recurrence rates suggest delayed identification of plantar ulceration for patients in diabetic foot remission.1 passage
• Recurrent diabetic ketoacidosis and cognitive function among older adults with type 1 diabetes: findings from the Study of Longevity in Diabetes.1 passage
• Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes.1 passage
• Reduced CD300LG mRNA tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of Arg82Cys in CD300LG: a novel genometabolic cross-link between CD300LG and common metabolic phenotypes.1 passage
• Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.1 passage
• Reduced first-phase insulin secretion increases postprandial lipidemia in subjects with impaired glucose tolerance.1 passage
• Reducing weight and BMI following gestational diabetes: a systematic review and meta-analysis of digital and telemedicine interventions.1 passage
• Regional difference in the susceptibility of non-alcoholic fatty liver disease in China.1 passage
• Regular performance feedback may be key to maintain good quality DKA management: results from a five-year study.1 passage
• Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.1 passage
• Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women's Medical University (DIACET).1 passage
• Relationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational study.1 passage
• Relationship of obesity to adipose tissue insulin resistance.1 passage
• Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage.1 passage
• Remission of pre-diabetes to normal glucose tolerance in obese adults with high protein versus high carbohydrate diet: randomized control trial.1 passage
• Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.1 passage
• Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes.1 passage
• Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS).1 passage
• Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using1 passage
• Results from NEXT-D: the association of a pre-diabetes-specific health plan and rates of incident diabetes among a national sample of working-age adults.1 passage
• Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.1 passage
• Risk factors for 30-day readmission following hypoglycemia-related emergency room and inpatient admissions.1 passage
• Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19.1 passage
• Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation.1 passage
• Risk factors for new-onset diabetes mellitus after distal pancreatectomy.1 passage
• Risk of 16 cancers across the full glycemic spectrum: a population-based cohort study using the UK Biobank.1 passage
• Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden.1 passage
• Risk of chronic kidney disease defined by decreased estimated glomerular filtration rate in individuals with different prediabetic phenotypes: results from a prospective cohort study in China.1 passage
• Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).1 passage
• Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population.1 passage
• Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes.1 passage
• Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study.1 passage
• Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans.1 passage
• Role of depression in diabetes management in an ethnic minority population: a case of Korean Americans with type 2 diabetes.1 passage
• Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.1 passage
• Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus.1 passage
• Role of the DNA repair genes1 passage
• SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews.1 passage
• Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.1 passage
• Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease.1 passage
• Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes.1 passage
• Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland.1 passage
• Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.1 passage
• Seasonality of gestational diabetes mellitus: a South Australian population study.1 passage
• Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus.1 passage
• Secreted factors from dental pulp stem cells improve glucose intolerance in streptozotocin-induced diabetic mice by increasing pancreatic β-cell function.1 passage
• Secular incidence trends and effect of population aging on mortality due to type 1 and type 2 diabetes mellitus in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019.1 passage
• Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.1 passage
• Selenium supplementation and insulin resistance in a randomized, clinical trial.1 passage
• Self-efficacy and diabetes prevention in overweight South Asians with pre-diabetes.1 passage
• Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study.1 passage
• Self-reported and objectively measured physical activity levels among Hispanic/Latino adults with type 2 diabetes.1 passage
• Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.1 passage
• Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population.1 passage
• Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus.1 passage
• Serum cell-free DNA and progression of diabetic kidney disease: a prospective study.1 passage
• Serum galectin-3BP as a novel marker of obesity and metabolic syndrome in Chinese adolescents.1 passage
• Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes.1 passage
• Serum microRNA as indicators of Wolfram syndrome's progression in neuroimaging studies.1 passage
• Serum vitamin K1 passage
• Service user and community clinician design of a partially virtual diabetic service improves access to care and education and reduces amputation incidence.1 passage
• Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort.1 passage
• Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes.1 passage
• Sex differences in the association of fasting and postchallenge glucose levels with grip strength among older adults: the Rancho Bernardo Study.1 passage
• Sex dimorphism in the associations of gestational diabetes with cord blood adiponectin and retinol-binding protein 4.1 passage
• Sex, diabetes status and cognition: findings from the study of longevity in diabetes.1 passage
• Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin.1 passage
• Shared genetic architecture and casual relationship between leptin levels and type 2 diabetes: large-scale cross-trait meta-analysis and Mendelian randomization analysis.1 passage
• Simple and non-invasive screening method for diabetes based on myoinositol levels in urine samples collected at home.1 passage
• Simple, Mobile-based Artificial Intelligence Algo1 passage
• Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.1 passage
• Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study.1 passage
• Skin autofluorescence predicts cancer in subjects with type 2 diabetes.1 passage
• Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication.1 passage
• Social determinants of health impacting adherence to diabetic retinopathy examinations.1 passage
• Sociodemographic and behavioral characteristics associated with self-reported diagnosed diabetes mellitus in adults aged 50+ years in Ghana and South Africa: results from the WHO-SAGE wave 1.1 passage
• Socioeconomic deprivation and development of diabetic retinopathy in patients with type 1 diabetes mellitus.1 passage
• Socioeconomic status and ethnic variation associated with type 2 diabetes mellitus in patients with uncontrolled hypertension in Singapore.1 passage
• Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis.1 passage
• Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?1 passage
• Spousal concordance in pathophysiological markers and risk factors for type 2 diabetes: a cross-sectional analysis of The Maastricht Study.1 passage
• Stages of change for physical activity and dietary habits in persons with type 2 diabetes included in a mobile health intervention: the Norwegian study in RENEWING HEALTH.1 passage
• Standardized screening for periodontitis as an integral part of multidisciplinary management of adults with type 2 diabetes: an observational cross-sectional study of cohorts in the USA and UK.1 passage
• Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.1 passage
• Structured lifestyle intervention based on a trans-cultural diabetes-specific nutrition algorithm (tDNA) in individuals with type 2 diabetes: a randomized controlled trial.1 passage
• Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey.1 passage
• Superior socioeconomic status in patients with type 2 diabetes having gastric bypass surgery: a case-control analysis of 10 642 individuals.1 passage
• Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events.1 passage
• Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems.1 passage
• System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015.1 passage
• Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes.1 passage
• Systemic inflammatory responses in patients with type 2 diabetes with chronic periodontitis.1 passage
• Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer.1 passage
• The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany.1 passage
• The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM).1 passage
• The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies.1 passage
• The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failure.1 passage
• The changing landscape of diabetes prevalence among first-generation Asian immigrants in California from 2003 to 2013.1 passage
• The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes.1 passage
• The effect of free diabetes care on metabolic control and on health-related quality of life among youths with type 1 diabetes in Cameroon.1 passage
• The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial.1 passage
• The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial.1 passage
• The relationship of individual comorbid chronic conditions to diabetes care quality.1 passage
• The risk of total mortality and cardiovascular mortality associated with impaired glucose regulation in Tayside, Scotland, UK: a record-linkage study in 214 094 people.1 passage
• Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study.1 passage
• Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study.1 passage
• Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a Swiss population.1 passage
• Time in range-A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study.1 passage
• Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetes.1 passage
• Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009-2018: a retrospective cohort study.1 passage
• Timing of access to secondary healthcare services and lower extremity amputations in patients with diabetes: a case-control study.1 passage
• Tissue inhibitor matrix metalloproteinase 1 and risk of type 2 diabetes in a Chinese population.1 passage
• Total energy expenditure is comparable between patients with and without diabetes mellitus: Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) Study.1 passage
• Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset.1 passage
• Trajectories of early to mid-life adulthood BMI and incident diabetes: the China Health and Nutrition Survey.1 passage
• Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes.1 passage
• Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study.1 passage
• Treatment patterns and clinical characteristics of patients with type 2 diabetes mellitus according to body mass index: findings from an electronic medical records database.1 passage
• Trends in inpatient admissions and emergency department visits for heart failure in adults with versus without diabetes in the USA, 2006-2017.1 passage
• Trends in prevalence of pre-existing diabetes and perinatal outcomes: a large, population-based study in Catalonia, Spain, 2006-2015.1 passage
• Trends in type 2 diabetes detection among adults in the USA, 1999-2014.1 passage
• Trigger finger is associated with risk of incident cardiovascular disease in individuals with type 2 diabetes: a retrospective cohort study.1 passage
• Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis.1 passage
• Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease.1 passage
• Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6).1 passage
• Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth.1 passage
• Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.1 passage
• Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening.1 passage
• Type 2 diabetes patient's perspective on Ramadan fasting: a qualitative study.1 passage
• Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012.1 passage
• Understanding the complexity of socioeconomic disparities in type 2 diabetes risk: a study of 4.3 million people in Sweden.1 passage
• Undiagnosed diabetes and impaired fasting glucose in1 passage
• Undiagnosed diabetes based on HbA1 passage
• Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission.1 passage
• Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion.1 passage
• Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy.1 passage
• Urinary metals and incident diabetes in midlife women: Study of Women's Health Across the Nation (SWAN).1 passage
• Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study.1 passage
• Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study.1 passage
• Use of an electronic health record to identify prevalent and incident cardiovascular disease in type 2 diabetes according to treatment strategy.1 passage
• Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program.1 passage
• Using a community-based participatory research approach to meaningfully engage those with lived experience of diabetes and homelessness.1 passage
• Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes.1 passage
• Validation and feasibility of a postal system for remote monitoring of HbA1c.1 passage
• Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada.1 passage
• Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys.1 passage
• Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study.1 passage
• Validity of ICD-10-CM codes for determination of diabetes type for persons with youth-onset type 1 and type 2 diabetes.1 passage
• Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.1 passage
• Variability in estimated glomerular filtration rate and the incidence of type 2 diabetes: a nationwide population-based study.1 passage
• Variability in preventive care practices among US adults with diabetes mellitus.1 passage
• Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3).1 passage
• Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes.1 passage
• Variation in hypoglycemia ascertainment and report in type 2 diabetes observational studies: a meta-epidemiological study.1 passage
• Visual impairment and mortality in patients with type 2 diabetes.1 passage
• Vitamin B1 passage
• Vitamin D for the treatment of painful diabetic neuropathy.1 passage
• Vitamin D status and risk of type 2 diabetes in the Norwegian HUNT cohort study: does family history or genetic predisposition modify the association?1 passage
• Volumetric evaluation of lumbar epidural fat distribution in epidural lipomatosis and back pain in patients who are obese: introducing a novel technique (Fat Finder algorithm).1 passage
• Walnut ingestion in adults at risk for diabetes: effects on body composition, diet quality, and cardiac risk measures.1 passage
• Weight loss efficacy of a novel mobile Diabetes Prevention Program delivery platform with human coaching.1 passage
• What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity.1 passage
• White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia.1 passage
• Willingness of patients with diabetes to use an ICT-based self-management tool: a cross-sectional study.1 passage
• Years of potential life lost in pre-diabetes and diabetes mellitus: data from a 40-year follow-up of the Israel study on Glucose intolerance, Obesity and Hypertension.1 passage
• Zinc transporter 8 autoantibody testing requires age-related cut-offs.1 passage
• apoA2 correlates to gestational age with decreased apolipoproteins A2, C1, C3 and E in gestational diabetes.1 passage
• miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes.1 passage
• tRNA methyltransferase 10 homologue A (1 passage
• β-Cell function or insulin resistance was associated with the risk of type 2 diabetes among women with or without obesity and a history of gestational diabetes.1 passage